Journal Article Inhibition of histone deacetylases enhances the function of serotoninergic neurons in organotypic raphe slice cultures.

Asaoka, Nozomi  ,  Nagayasu, Kazuki  ,  Nishitani, Naoya  ,  Yamashiro, Mayumi  ,  Shirakawa, Hisashi  ,  Nakagawa, Takayuki  ,  Kaneko, Shuji

593pp.72 - 77 , 2015-04-23 , Elsevier
ISSN:0304-3940
NCID:AA00754925
Description
Inhibition of histone deacetylases (HDACs) is a promising approach for the treatment of mood disorders. However, the effects of HDAC inhibition on the serotonin (5-HT) system, a common target for psychiatric disorders, are poorly understood. Here, we show that a broad-spectrum HDAC inhibitor, trichostatin A (TSA), enhances the function of 5-HT neurons in organotypic raphe slice cultures. Sustained treatment with TSA (1μM) for 2 or 4 days significantly increased the 5-HT tissue content and tryptophan hydroxylase 2 (TPH2) expression, which were accompanied by hyper-acetylation of histone H3 in the promoter region of the TPH2 gene. TSA treatment for 4 days increased the extracellular 5-HT level, which was significantly suppressed in the presence of the selective AMPA receptor (AMPAR) antagonist NBQX. Moreover, the expression of both the AMPAR subunit GluA2 and Ca(2+)/calmodulin-dependent kinase II α (CaMKIIα) mRNAs were significantly increased by TSA treatment. Co-treatment with the CaMKII inhibitors KN-62 and KN-93 prevented the TSA-induced increase in 5-HT release, but had no effect on the increases in 5-HT tissue content. These results suggest that inhibition of HDACs increases 5-HT synthesis and release by epigenetic mechanisms, and that 5-HT release is mediated by the enhancement of AMPAR-mediated excitatory inputs and CaMKII signaling.
Full-Text

http://repository.kulib.kyoto-u.ac.jp/dspace/bitstream/2433/200191/1/j.neulet.2015.03.028.pdf

Number of accesses :  

Other information